TAMPA, Fla., Jan. 26, 2016 -- PPJ Healthcare Enterprises Inc. (OTC Pink:PPJE) announced today that the Board has voted to cancel its pending reverse stock split. The decision to cancel the reverse split is part of the Company’s latest actions to improve shareholder relations and value including the reduction of its authorized from 20 Billion to 5 Billion and the exchange of 2.5 Billion shares by the CEO for Preferred Class B Shares. These recent corporate actions will result in the Company having 5 Billion authorized common shares with approximately 1.5 Billion outstanding and no reverse split.
“Avoiding this reverse split and cutting our common share by 75 percent were important steps in rebuilding shareholders' value and trust,” said Chandana Basu, CEO of PPJ Healthcare Enterprises Inc.
"The next key to progress for the Company and shareholders is to work with our debt holders in a shareholder friendly manner, which we are pleased to say such discussions are well underway," noted Basu.
The Automated Biller, the company’s revolutionary medical billing system, recently launched its online demonstration and it will be displayed at more medical conferences in multiple states.
“Our company remains steadfast in providing the healthcare industry with a product that will reshape the industry,” Basu said. “Our product, along with our faithful and future investors, paves the way for a future that will revolutionize our outlook.”
PPJE management advises shareholders, company followers and prospective investors to contact their financial advisors if they have any questions or concerns about their individual accounts and investment choices.
Forward-looking Statements
Information in this release may contain statements about future expectations, plans, prospects or performance of PPJ Healthcare Enterprises Inc. that constitute forward-looking statements for purposes of the Safe Harbor Provisions under the Private Securities Litigation Reform Act of 1995. The words or phrases “can be,” “expects,” “may affect,” “believed,” “estimate,” “project” and similar words and phrases are intended to identify such forward-looking statements. PPJ Healthcare Enterprises cautions you that any forward-looking information provided by or on behalf of PPJ Enterprise is not a guarantee of future performance. None of the information in this press release constituted or is intended as an offer to sell securities or investment advice of any kind. PPJ Healthcare Enterprises’ actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond PPJ Enterprise’s control. All such forward-looking statements are current only as of the date on which such statements were made. PPJ Healthcare Enterprises does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made to reflect the occurrence of unanticipated events.
PPJ Healthcare Enterprises, Inc. 401 E. Jackson St., Suite 2340 Tampa, Florida 33602 Telephone: (813) 693-5192 Fax: (866) 622-3215 Websites: https://www.ppjenterprise.com


ASML Raises 2026 Outlook as AI Chip Demand Lifts Q2 Earnings
Stripe, Advent Offer $53 Billion Deal to Acquire PayPal: Reuters
Airbus Signs Cloud Deal With Scaleway to Power Secure AI and Defense Applications
Nvidia Partners With Fanuc and Yaskawa to Accelerate AI Robotics in Japan
Alibaba Stock Jumps as China Approves Apple Intelligence Powered by Qwen AI
SEB Q2 Profit Rises on Strong Lending, Record Fee Income, Announces New Share Buyback
Apple Intelligence Cleared for China as Alibaba and Baidu AI Power iPhone Features
BHP Faces Major Port Hedland Strike as Labor Talks Stall Ahead of Production Report
DBS Targets S$1 Trillion Wealth AUM by 2030 Amid Asia Wealth Boom
xAI Sues Man for Allegedly Using Grok to Generate AI Child Abuse Deepfakes
Taiwan Mangoes Head to Europe as Premium Fruit Exports Expand
Rio Tinto Reports Strong Q2 Iron Ore Sales, Maintains 2026 Production Outlook
Hyundai Takes Full Control of Boston Dynamics to Accelerate Humanoid Robot and AI Strategy
NY Times Challenges Trump Administration Subpoenas Over Air Force One Report
Apple Intelligence China Approval Lifts Alibaba and Baidu Shares
Richemont Q1 Sales Beat Forecast as Cartier Demand Drives Strong Growth
Paramount-Warner Bros. Discovery Merger Faces Lawsuit From 12 States 



